nodes	percent_of_prediction	percent_of_DWPC	metapath
Sorafenib—ABCG2—Omeprazole—Barrett's esophagus	0.118	0.208	CbGbCtD
Sorafenib—CYP2C19—Esomeprazole—Barrett's esophagus	0.0898	0.158	CbGbCtD
Sorafenib—CYP2C8—Omeprazole—Barrett's esophagus	0.0631	0.111	CbGbCtD
Sorafenib—CYP2C19—Omeprazole—Barrett's esophagus	0.0529	0.093	CbGbCtD
Sorafenib—CYP1A2—Omeprazole—Barrett's esophagus	0.0488	0.0858	CbGbCtD
Sorafenib—CYP2C9—Omeprazole—Barrett's esophagus	0.044	0.0773	CbGbCtD
Sorafenib—CYP3A4—Esomeprazole—Barrett's esophagus	0.0434	0.0763	CbGbCtD
Sorafenib—ABCB1—Omeprazole—Barrett's esophagus	0.0427	0.075	CbGbCtD
Sorafenib—CYP2D6—Omeprazole—Barrett's esophagus	0.0402	0.0707	CbGbCtD
Sorafenib—CYP3A4—Omeprazole—Barrett's esophagus	0.0256	0.045	CbGbCtD
Sorafenib—Varices oesophageal—Esomeprazole—Barrett's esophagus	0.0211	0.0931	CcSEcCtD
Sorafenib—Varices oesophageal—Omeprazole—Barrett's esophagus	0.0211	0.0931	CcSEcCtD
Sorafenib—ABCC2—bile—Barrett's esophagus	0.00821	0.0914	CbGeAlD
Sorafenib—Allergic cutaneous angiitis—Omeprazole—Barrett's esophagus	0.00552	0.0244	CcSEcCtD
Sorafenib—Allergic cutaneous angiitis—Esomeprazole—Barrett's esophagus	0.00552	0.0244	CcSEcCtD
Sorafenib—Nephrotic syndrome—Esomeprazole—Barrett's esophagus	0.00363	0.0161	CcSEcCtD
Sorafenib—Nephrotic syndrome—Omeprazole—Barrett's esophagus	0.00363	0.0161	CcSEcCtD
Sorafenib—KIT—exocrine gland—Barrett's esophagus	0.0036	0.0401	CbGeAlD
Sorafenib—Leukocytoclastic vasculitis—Omeprazole—Barrett's esophagus	0.00358	0.0158	CcSEcCtD
Sorafenib—Leukocytoclastic vasculitis—Esomeprazole—Barrett's esophagus	0.00358	0.0158	CcSEcCtD
Sorafenib—TIE1—epithelium—Barrett's esophagus	0.00325	0.0362	CbGeAlD
Sorafenib—TIE1—smooth muscle tissue—Barrett's esophagus	0.00314	0.0349	CbGeAlD
Sorafenib—ZAK—digestive system—Barrett's esophagus	0.00271	0.0301	CbGeAlD
Sorafenib—FLT4—epithelium—Barrett's esophagus	0.00269	0.0299	CbGeAlD
Sorafenib—HIPK3—digestive system—Barrett's esophagus	0.00265	0.0295	CbGeAlD
Sorafenib—MKNK2—epithelium—Barrett's esophagus	0.00243	0.0271	CbGeAlD
Sorafenib—MAP3K7—smooth muscle tissue—Barrett's esophagus	0.00242	0.0269	CbGeAlD
Sorafenib—RET—epithelium—Barrett's esophagus	0.00237	0.0264	CbGeAlD
Sorafenib—MKNK2—smooth muscle tissue—Barrett's esophagus	0.00235	0.0261	CbGeAlD
Sorafenib—Tubulointerstitial nephritis—Esomeprazole—Barrett's esophagus	0.00229	0.0101	CcSEcCtD
Sorafenib—Tubulointerstitial nephritis—Omeprazole—Barrett's esophagus	0.00229	0.0101	CcSEcCtD
Sorafenib—RALBP1—smooth muscle tissue—Barrett's esophagus	0.00212	0.0236	CbGeAlD
Sorafenib—FLT1—epithelium—Barrett's esophagus	0.00209	0.0233	CbGeAlD
Sorafenib—RAF1—epithelium—Barrett's esophagus	0.00208	0.0231	CbGeAlD
Sorafenib—UGT1A9—digestive system—Barrett's esophagus	0.00207	0.0231	CbGeAlD
Sorafenib—FLT1—smooth muscle tissue—Barrett's esophagus	0.00201	0.0224	CbGeAlD
Sorafenib—RAF1—smooth muscle tissue—Barrett's esophagus	0.002	0.0223	CbGeAlD
Sorafenib—Proteinuria—Omeprazole—Barrett's esophagus	0.002	0.00883	CcSEcCtD
Sorafenib—Proteinuria—Esomeprazole—Barrett's esophagus	0.002	0.00883	CcSEcCtD
Sorafenib—Protein urine present—Esomeprazole—Barrett's esophagus	0.00197	0.00871	CcSEcCtD
Sorafenib—Protein urine present—Omeprazole—Barrett's esophagus	0.00197	0.00871	CcSEcCtD
Sorafenib—Gastrooesophageal reflux disease—Omeprazole—Barrett's esophagus	0.00194	0.00859	CcSEcCtD
Sorafenib—Bone disorder—Esomeprazole—Barrett's esophagus	0.00194	0.00859	CcSEcCtD
Sorafenib—Bone disorder—Omeprazole—Barrett's esophagus	0.00194	0.00859	CcSEcCtD
Sorafenib—Gastrooesophageal reflux disease—Esomeprazole—Barrett's esophagus	0.00194	0.00859	CcSEcCtD
Sorafenib—Hypocalcaemia—Esomeprazole—Barrett's esophagus	0.00192	0.00848	CcSEcCtD
Sorafenib—Hypocalcaemia—Omeprazole—Barrett's esophagus	0.00192	0.00848	CcSEcCtD
Sorafenib—Glossitis—Esomeprazole—Barrett's esophagus	0.0019	0.00842	CcSEcCtD
Sorafenib—Glossitis—Omeprazole—Barrett's esophagus	0.0019	0.00842	CcSEcCtD
Sorafenib—PDGFRA—smooth muscle tissue—Barrett's esophagus	0.00189	0.021	CbGeAlD
Sorafenib—MKNK2—digestive system—Barrett's esophagus	0.00185	0.0206	CbGeAlD
Sorafenib—MKNK1—digestive system—Barrett's esophagus	0.00183	0.0204	CbGeAlD
Sorafenib—RET—digestive system—Barrett's esophagus	0.00181	0.0201	CbGeAlD
Sorafenib—KDR—epithelium—Barrett's esophagus	0.00177	0.0197	CbGeAlD
Sorafenib—Blood pressure increased—Omeprazole—Barrett's esophagus	0.00175	0.00776	CcSEcCtD
Sorafenib—Blood pressure increased—Esomeprazole—Barrett's esophagus	0.00175	0.00776	CcSEcCtD
Sorafenib—KDR—smooth muscle tissue—Barrett's esophagus	0.0017	0.019	CbGeAlD
Sorafenib—RALBP1—digestive system—Barrett's esophagus	0.00167	0.0186	CbGeAlD
Sorafenib—CSF1R—smooth muscle tissue—Barrett's esophagus	0.00166	0.0185	CbGeAlD
Sorafenib—FLT1—digestive system—Barrett's esophagus	0.00159	0.0177	CbGeAlD
Sorafenib—Neoplasm—Esomeprazole—Barrett's esophagus	0.00159	0.00702	CcSEcCtD
Sorafenib—Mouth ulceration—Esomeprazole—Barrett's esophagus	0.00159	0.00702	CcSEcCtD
Sorafenib—Neoplasm—Omeprazole—Barrett's esophagus	0.00159	0.00702	CcSEcCtD
Sorafenib—Mouth ulceration—Omeprazole—Barrett's esophagus	0.00159	0.00702	CcSEcCtD
Sorafenib—RAF1—digestive system—Barrett's esophagus	0.00158	0.0176	CbGeAlD
Sorafenib—Gynaecomastia—Esomeprazole—Barrett's esophagus	0.00157	0.00694	CcSEcCtD
Sorafenib—Gynaecomastia—Omeprazole—Barrett's esophagus	0.00157	0.00694	CcSEcCtD
Sorafenib—KIT—epithelium—Barrett's esophagus	0.00157	0.0174	CbGeAlD
Sorafenib—PDGFRB—epithelium—Barrett's esophagus	0.00153	0.017	CbGeAlD
Sorafenib—KIT—smooth muscle tissue—Barrett's esophagus	0.00151	0.0168	CbGeAlD
Sorafenib—STK10—digestive system—Barrett's esophagus	0.00151	0.0168	CbGeAlD
Sorafenib—PDGFRA—digestive system—Barrett's esophagus	0.00149	0.0166	CbGeAlD
Sorafenib—PDGFRB—smooth muscle tissue—Barrett's esophagus	0.00147	0.0164	CbGeAlD
Sorafenib—Hepatic function abnormal—Omeprazole—Barrett's esophagus	0.00146	0.00645	CcSEcCtD
Sorafenib—Hepatic function abnormal—Esomeprazole—Barrett's esophagus	0.00146	0.00645	CcSEcCtD
Sorafenib—UGT1A1—digestive system—Barrett's esophagus	0.00142	0.0158	CbGeAlD
Sorafenib—Hepatic failure—Omeprazole—Barrett's esophagus	0.00142	0.00627	CcSEcCtD
Sorafenib—Hepatic failure—Esomeprazole—Barrett's esophagus	0.00142	0.00627	CcSEcCtD
Sorafenib—KDR—digestive system—Barrett's esophagus	0.00134	0.015	CbGeAlD
Sorafenib—CSF1R—digestive system—Barrett's esophagus	0.00131	0.0146	CbGeAlD
Sorafenib—Hyponatraemia—Esomeprazole—Barrett's esophagus	0.00128	0.00566	CcSEcCtD
Sorafenib—Hyponatraemia—Omeprazole—Barrett's esophagus	0.00128	0.00566	CcSEcCtD
Sorafenib—Pain in extremity—Esomeprazole—Barrett's esophagus	0.00127	0.00563	CcSEcCtD
Sorafenib—Pain in extremity—Omeprazole—Barrett's esophagus	0.00127	0.00563	CcSEcCtD
Sorafenib—KIT—digestive system—Barrett's esophagus	0.00119	0.0133	CbGeAlD
Sorafenib—HTR2B—smooth muscle tissue—Barrett's esophagus	0.00117	0.013	CbGeAlD
Sorafenib—Dry skin—Esomeprazole—Barrett's esophagus	0.00117	0.00516	CcSEcCtD
Sorafenib—Dry skin—Omeprazole—Barrett's esophagus	0.00117	0.00516	CcSEcCtD
Sorafenib—PDGFRB—digestive system—Barrett's esophagus	0.00116	0.013	CbGeAlD
Sorafenib—Abdominal pain upper—Omeprazole—Barrett's esophagus	0.00116	0.00515	CcSEcCtD
Sorafenib—Abdominal pain upper—Esomeprazole—Barrett's esophagus	0.00116	0.00515	CcSEcCtD
Sorafenib—Hypokalaemia—Omeprazole—Barrett's esophagus	0.00116	0.00513	CcSEcCtD
Sorafenib—Hypokalaemia—Esomeprazole—Barrett's esophagus	0.00116	0.00513	CcSEcCtD
Sorafenib—Breast disorder—Esomeprazole—Barrett's esophagus	0.00115	0.00509	CcSEcCtD
Sorafenib—Breast disorder—Omeprazole—Barrett's esophagus	0.00115	0.00509	CcSEcCtD
Sorafenib—Toxic epidermal necrolysis—Omeprazole—Barrett's esophagus	0.00115	0.00507	CcSEcCtD
Sorafenib—Aspartate aminotransferase increased—Omeprazole—Barrett's esophagus	0.00115	0.00507	CcSEcCtD
Sorafenib—Toxic epidermal necrolysis—Esomeprazole—Barrett's esophagus	0.00115	0.00507	CcSEcCtD
Sorafenib—Aspartate aminotransferase increased—Esomeprazole—Barrett's esophagus	0.00115	0.00507	CcSEcCtD
Sorafenib—Gastritis—Esomeprazole—Barrett's esophagus	0.00113	0.00499	CcSEcCtD
Sorafenib—Gastritis—Omeprazole—Barrett's esophagus	0.00113	0.00499	CcSEcCtD
Sorafenib—Alanine aminotransferase increased—Omeprazole—Barrett's esophagus	0.00112	0.00497	CcSEcCtD
Sorafenib—Alanine aminotransferase increased—Esomeprazole—Barrett's esophagus	0.00112	0.00497	CcSEcCtD
Sorafenib—Dysphagia—Esomeprazole—Barrett's esophagus	0.0011	0.00487	CcSEcCtD
Sorafenib—Dysphagia—Omeprazole—Barrett's esophagus	0.0011	0.00487	CcSEcCtD
Sorafenib—Pancreatitis—Esomeprazole—Barrett's esophagus	0.00108	0.00477	CcSEcCtD
Sorafenib—Pancreatitis—Omeprazole—Barrett's esophagus	0.00108	0.00477	CcSEcCtD
Sorafenib—Neutropenia—Omeprazole—Barrett's esophagus	0.00103	0.00455	CcSEcCtD
Sorafenib—Neutropenia—Esomeprazole—Barrett's esophagus	0.00103	0.00455	CcSEcCtD
Sorafenib—Erectile dysfunction—Esomeprazole—Barrett's esophagus	0.00101	0.00448	CcSEcCtD
Sorafenib—Erectile dysfunction—Omeprazole—Barrett's esophagus	0.00101	0.00448	CcSEcCtD
Sorafenib—Weight decreased—Esomeprazole—Barrett's esophagus	0.000996	0.00441	CcSEcCtD
Sorafenib—Weight decreased—Omeprazole—Barrett's esophagus	0.000996	0.00441	CcSEcCtD
Sorafenib—Infestation—Omeprazole—Barrett's esophagus	0.000982	0.00434	CcSEcCtD
Sorafenib—Infestation NOS—Omeprazole—Barrett's esophagus	0.000982	0.00434	CcSEcCtD
Sorafenib—Infestation—Esomeprazole—Barrett's esophagus	0.000982	0.00434	CcSEcCtD
Sorafenib—Infestation NOS—Esomeprazole—Barrett's esophagus	0.000982	0.00434	CcSEcCtD
Sorafenib—Stevens-Johnson syndrome—Omeprazole—Barrett's esophagus	0.000973	0.0043	CcSEcCtD
Sorafenib—Stevens-Johnson syndrome—Esomeprazole—Barrett's esophagus	0.000973	0.0043	CcSEcCtD
Sorafenib—Renal failure—Omeprazole—Barrett's esophagus	0.000965	0.00427	CcSEcCtD
Sorafenib—Renal failure—Esomeprazole—Barrett's esophagus	0.000965	0.00427	CcSEcCtD
Sorafenib—Stomatitis—Omeprazole—Barrett's esophagus	0.000957	0.00423	CcSEcCtD
Sorafenib—Jaundice—Omeprazole—Barrett's esophagus	0.000957	0.00423	CcSEcCtD
Sorafenib—Stomatitis—Esomeprazole—Barrett's esophagus	0.000957	0.00423	CcSEcCtD
Sorafenib—Jaundice—Esomeprazole—Barrett's esophagus	0.000957	0.00423	CcSEcCtD
Sorafenib—Hepatobiliary disease—Omeprazole—Barrett's esophagus	0.000928	0.00411	CcSEcCtD
Sorafenib—Hepatobiliary disease—Esomeprazole—Barrett's esophagus	0.000928	0.00411	CcSEcCtD
Sorafenib—ABCC4—digestive system—Barrett's esophagus	0.000927	0.0103	CbGeAlD
Sorafenib—Epistaxis—Omeprazole—Barrett's esophagus	0.000926	0.00409	CcSEcCtD
Sorafenib—Epistaxis—Esomeprazole—Barrett's esophagus	0.000926	0.00409	CcSEcCtD
Sorafenib—HTR2B—digestive system—Barrett's esophagus	0.000922	0.0103	CbGeAlD
Sorafenib—ABCC2—digestive system—Barrett's esophagus	0.000897	0.00999	CbGeAlD
Sorafenib—Urinary tract disorder—Omeprazole—Barrett's esophagus	0.00087	0.00385	CcSEcCtD
Sorafenib—Urinary tract disorder—Esomeprazole—Barrett's esophagus	0.00087	0.00385	CcSEcCtD
Sorafenib—Connective tissue disorder—Esomeprazole—Barrett's esophagus	0.000866	0.00383	CcSEcCtD
Sorafenib—Connective tissue disorder—Omeprazole—Barrett's esophagus	0.000866	0.00383	CcSEcCtD
Sorafenib—Urethral disorder—Omeprazole—Barrett's esophagus	0.000864	0.00382	CcSEcCtD
Sorafenib—Urethral disorder—Esomeprazole—Barrett's esophagus	0.000864	0.00382	CcSEcCtD
Sorafenib—Erythema multiforme—Esomeprazole—Barrett's esophagus	0.000833	0.00368	CcSEcCtD
Sorafenib—Erythema multiforme—Omeprazole—Barrett's esophagus	0.000833	0.00368	CcSEcCtD
Sorafenib—Tinnitus—Omeprazole—Barrett's esophagus	0.000822	0.00363	CcSEcCtD
Sorafenib—Tinnitus—Esomeprazole—Barrett's esophagus	0.000822	0.00363	CcSEcCtD
Sorafenib—Flushing—Omeprazole—Barrett's esophagus	0.000818	0.00362	CcSEcCtD
Sorafenib—Flushing—Esomeprazole—Barrett's esophagus	0.000818	0.00362	CcSEcCtD
Sorafenib—Immune system disorder—Omeprazole—Barrett's esophagus	0.000796	0.00352	CcSEcCtD
Sorafenib—Immune system disorder—Esomeprazole—Barrett's esophagus	0.000796	0.00352	CcSEcCtD
Sorafenib—Mediastinal disorder—Omeprazole—Barrett's esophagus	0.000794	0.00351	CcSEcCtD
Sorafenib—Mediastinal disorder—Esomeprazole—Barrett's esophagus	0.000794	0.00351	CcSEcCtD
Sorafenib—Alopecia—Omeprazole—Barrett's esophagus	0.000779	0.00344	CcSEcCtD
Sorafenib—Alopecia—Esomeprazole—Barrett's esophagus	0.000779	0.00344	CcSEcCtD
Sorafenib—Mental disorder—Omeprazole—Barrett's esophagus	0.000772	0.00341	CcSEcCtD
Sorafenib—Mental disorder—Esomeprazole—Barrett's esophagus	0.000772	0.00341	CcSEcCtD
Sorafenib—CYP2C19—digestive system—Barrett's esophagus	0.000771	0.00858	CbGeAlD
Sorafenib—Malnutrition—Omeprazole—Barrett's esophagus	0.000767	0.00339	CcSEcCtD
Sorafenib—Malnutrition—Esomeprazole—Barrett's esophagus	0.000767	0.00339	CcSEcCtD
Sorafenib—Dysgeusia—Omeprazole—Barrett's esophagus	0.000751	0.00332	CcSEcCtD
Sorafenib—Dysgeusia—Esomeprazole—Barrett's esophagus	0.000751	0.00332	CcSEcCtD
Sorafenib—Muscle spasms—Esomeprazole—Barrett's esophagus	0.000737	0.00326	CcSEcCtD
Sorafenib—Muscle spasms—Omeprazole—Barrett's esophagus	0.000737	0.00326	CcSEcCtD
Sorafenib—Anaemia—Esomeprazole—Barrett's esophagus	0.000709	0.00314	CcSEcCtD
Sorafenib—Anaemia—Omeprazole—Barrett's esophagus	0.000709	0.00314	CcSEcCtD
Sorafenib—Angioedema—Omeprazole—Barrett's esophagus	0.000701	0.0031	CcSEcCtD
Sorafenib—Angioedema—Esomeprazole—Barrett's esophagus	0.000701	0.0031	CcSEcCtD
Sorafenib—Leukopenia—Esomeprazole—Barrett's esophagus	0.000687	0.00304	CcSEcCtD
Sorafenib—Leukopenia—Omeprazole—Barrett's esophagus	0.000687	0.00304	CcSEcCtD
Sorafenib—Cough—Omeprazole—Barrett's esophagus	0.000669	0.00296	CcSEcCtD
Sorafenib—Cough—Esomeprazole—Barrett's esophagus	0.000669	0.00296	CcSEcCtD
Sorafenib—Hypertension—Omeprazole—Barrett's esophagus	0.000662	0.00293	CcSEcCtD
Sorafenib—Hypertension—Esomeprazole—Barrett's esophagus	0.000662	0.00293	CcSEcCtD
Sorafenib—Arthralgia—Omeprazole—Barrett's esophagus	0.000653	0.00289	CcSEcCtD
Sorafenib—Myalgia—Esomeprazole—Barrett's esophagus	0.000653	0.00289	CcSEcCtD
Sorafenib—Arthralgia—Esomeprazole—Barrett's esophagus	0.000653	0.00289	CcSEcCtD
Sorafenib—Myalgia—Omeprazole—Barrett's esophagus	0.000653	0.00289	CcSEcCtD
Sorafenib—Unspecified disorder of skin and subcutaneous tissue—Omeprazole—Barrett's esophagus	0.000649	0.00287	CcSEcCtD
Sorafenib—Unspecified disorder of skin and subcutaneous tissue—Esomeprazole—Barrett's esophagus	0.000649	0.00287	CcSEcCtD
Sorafenib—Dry mouth—Esomeprazole—Barrett's esophagus	0.000639	0.00282	CcSEcCtD
Sorafenib—Dry mouth—Omeprazole—Barrett's esophagus	0.000639	0.00282	CcSEcCtD
Sorafenib—CYP1A2—digestive system—Barrett's esophagus	0.00063	0.00701	CbGeAlD
Sorafenib—Anaphylactic shock—Omeprazole—Barrett's esophagus	0.000626	0.00277	CcSEcCtD
Sorafenib—Anaphylactic shock—Esomeprazole—Barrett's esophagus	0.000626	0.00277	CcSEcCtD
Sorafenib—Infection—Esomeprazole—Barrett's esophagus	0.000622	0.00275	CcSEcCtD
Sorafenib—Infection—Omeprazole—Barrett's esophagus	0.000622	0.00275	CcSEcCtD
Sorafenib—Shock—Esomeprazole—Barrett's esophagus	0.000616	0.00272	CcSEcCtD
Sorafenib—Shock—Omeprazole—Barrett's esophagus	0.000616	0.00272	CcSEcCtD
Sorafenib—Nervous system disorder—Omeprazole—Barrett's esophagus	0.000614	0.00272	CcSEcCtD
Sorafenib—Nervous system disorder—Esomeprazole—Barrett's esophagus	0.000614	0.00272	CcSEcCtD
Sorafenib—Thrombocytopenia—Esomeprazole—Barrett's esophagus	0.000613	0.00271	CcSEcCtD
Sorafenib—Thrombocytopenia—Omeprazole—Barrett's esophagus	0.000613	0.00271	CcSEcCtD
Sorafenib—Skin disorder—Esomeprazole—Barrett's esophagus	0.000608	0.00269	CcSEcCtD
Sorafenib—Skin disorder—Omeprazole—Barrett's esophagus	0.000608	0.00269	CcSEcCtD
Sorafenib—CYP3A5—digestive system—Barrett's esophagus	0.000607	0.00676	CbGeAlD
Sorafenib—CYP2B6—digestive system—Barrett's esophagus	0.000604	0.00672	CbGeAlD
Sorafenib—CYP2C9—digestive system—Barrett's esophagus	0.000598	0.00665	CbGeAlD
Sorafenib—Anorexia—Omeprazole—Barrett's esophagus	0.000597	0.00264	CcSEcCtD
Sorafenib—Anorexia—Esomeprazole—Barrett's esophagus	0.000597	0.00264	CcSEcCtD
Sorafenib—Musculoskeletal discomfort—Esomeprazole—Barrett's esophagus	0.00057	0.00252	CcSEcCtD
Sorafenib—Musculoskeletal discomfort—Omeprazole—Barrett's esophagus	0.00057	0.00252	CcSEcCtD
Sorafenib—Dyspnoea—Esomeprazole—Barrett's esophagus	0.000558	0.00247	CcSEcCtD
Sorafenib—Dyspnoea—Omeprazole—Barrett's esophagus	0.000558	0.00247	CcSEcCtD
Sorafenib—Dyspepsia—Omeprazole—Barrett's esophagus	0.000551	0.00244	CcSEcCtD
Sorafenib—Dyspepsia—Esomeprazole—Barrett's esophagus	0.000551	0.00244	CcSEcCtD
Sorafenib—Decreased appetite—Omeprazole—Barrett's esophagus	0.000544	0.00241	CcSEcCtD
Sorafenib—Decreased appetite—Esomeprazole—Barrett's esophagus	0.000544	0.00241	CcSEcCtD
Sorafenib—Gastrointestinal disorder—Esomeprazole—Barrett's esophagus	0.00054	0.00239	CcSEcCtD
Sorafenib—Gastrointestinal disorder—Omeprazole—Barrett's esophagus	0.00054	0.00239	CcSEcCtD
Sorafenib—Fatigue—Omeprazole—Barrett's esophagus	0.00054	0.00239	CcSEcCtD
Sorafenib—Fatigue—Esomeprazole—Barrett's esophagus	0.00054	0.00239	CcSEcCtD
Sorafenib—Pain—Esomeprazole—Barrett's esophagus	0.000535	0.00237	CcSEcCtD
Sorafenib—Constipation—Esomeprazole—Barrett's esophagus	0.000535	0.00237	CcSEcCtD
Sorafenib—Pain—Omeprazole—Barrett's esophagus	0.000535	0.00237	CcSEcCtD
Sorafenib—Constipation—Omeprazole—Barrett's esophagus	0.000535	0.00237	CcSEcCtD
Sorafenib—Gastrointestinal pain—Esomeprazole—Barrett's esophagus	0.000512	0.00226	CcSEcCtD
Sorafenib—Gastrointestinal pain—Omeprazole—Barrett's esophagus	0.000512	0.00226	CcSEcCtD
Sorafenib—Urticaria—Esomeprazole—Barrett's esophagus	0.000497	0.0022	CcSEcCtD
Sorafenib—Urticaria—Omeprazole—Barrett's esophagus	0.000497	0.0022	CcSEcCtD
Sorafenib—Body temperature increased—Esomeprazole—Barrett's esophagus	0.000495	0.00219	CcSEcCtD
Sorafenib—Abdominal pain—Omeprazole—Barrett's esophagus	0.000495	0.00219	CcSEcCtD
Sorafenib—Body temperature increased—Omeprazole—Barrett's esophagus	0.000495	0.00219	CcSEcCtD
Sorafenib—Abdominal pain—Esomeprazole—Barrett's esophagus	0.000495	0.00219	CcSEcCtD
Sorafenib—Hypersensitivity—Esomeprazole—Barrett's esophagus	0.000461	0.00204	CcSEcCtD
Sorafenib—Hypersensitivity—Omeprazole—Barrett's esophagus	0.000461	0.00204	CcSEcCtD
Sorafenib—CYP3A4—digestive system—Barrett's esophagus	0.000456	0.00507	CbGeAlD
Sorafenib—Asthenia—Omeprazole—Barrett's esophagus	0.000449	0.00199	CcSEcCtD
Sorafenib—Asthenia—Esomeprazole—Barrett's esophagus	0.000449	0.00199	CcSEcCtD
Sorafenib—CYP2D6—digestive system—Barrett's esophagus	0.000448	0.00499	CbGeAlD
Sorafenib—Pruritus—Omeprazole—Barrett's esophagus	0.000443	0.00196	CcSEcCtD
Sorafenib—Pruritus—Esomeprazole—Barrett's esophagus	0.000443	0.00196	CcSEcCtD
Sorafenib—Diarrhoea—Omeprazole—Barrett's esophagus	0.000428	0.00189	CcSEcCtD
Sorafenib—Diarrhoea—Esomeprazole—Barrett's esophagus	0.000428	0.00189	CcSEcCtD
Sorafenib—ABCB1—epithelium—Barrett's esophagus	0.000424	0.00472	CbGeAlD
Sorafenib—Dizziness—Omeprazole—Barrett's esophagus	0.000414	0.00183	CcSEcCtD
Sorafenib—Dizziness—Esomeprazole—Barrett's esophagus	0.000414	0.00183	CcSEcCtD
Sorafenib—Vomiting—Omeprazole—Barrett's esophagus	0.000398	0.00176	CcSEcCtD
Sorafenib—Vomiting—Esomeprazole—Barrett's esophagus	0.000398	0.00176	CcSEcCtD
Sorafenib—Rash—Esomeprazole—Barrett's esophagus	0.000395	0.00175	CcSEcCtD
Sorafenib—Rash—Omeprazole—Barrett's esophagus	0.000395	0.00175	CcSEcCtD
Sorafenib—Dermatitis—Esomeprazole—Barrett's esophagus	0.000394	0.00174	CcSEcCtD
Sorafenib—Dermatitis—Omeprazole—Barrett's esophagus	0.000394	0.00174	CcSEcCtD
Sorafenib—Headache—Esomeprazole—Barrett's esophagus	0.000392	0.00173	CcSEcCtD
Sorafenib—Headache—Omeprazole—Barrett's esophagus	0.000392	0.00173	CcSEcCtD
Sorafenib—Nausea—Esomeprazole—Barrett's esophagus	0.000372	0.00164	CcSEcCtD
Sorafenib—Nausea—Omeprazole—Barrett's esophagus	0.000372	0.00164	CcSEcCtD
Sorafenib—ABCB1—digestive system—Barrett's esophagus	0.000323	0.00359	CbGeAlD
Sorafenib—ABCG2—Metabolism—PTGES—Barrett's esophagus	5.17e-05	0.00045	CbGpPWpGaD
Sorafenib—HTR2C—Signaling by GPCR—GAST—Barrett's esophagus	5.16e-05	0.000449	CbGpPWpGaD
Sorafenib—MAPK11—Signaling Pathways—GAST—Barrett's esophagus	5.15e-05	0.000448	CbGpPWpGaD
Sorafenib—FGFR1—MAPK Signaling Pathway—TP53—Barrett's esophagus	5.15e-05	0.000448	CbGpPWpGaD
Sorafenib—EPHX2—Metabolism—PPARG—Barrett's esophagus	5.14e-05	0.000447	CbGpPWpGaD
Sorafenib—CYP3A7—Metabolism—PTGES—Barrett's esophagus	5.12e-05	0.000446	CbGpPWpGaD
Sorafenib—KDR—Developmental Biology—RELA—Barrett's esophagus	5.1e-05	0.000444	CbGpPWpGaD
Sorafenib—BRAF—Signaling Pathways—GAST—Barrett's esophagus	5.1e-05	0.000444	CbGpPWpGaD
Sorafenib—RAF1—Hemostasis—HGF—Barrett's esophagus	5.09e-05	0.000442	CbGpPWpGaD
Sorafenib—KIT—Disease—SLC9A1—Barrett's esophagus	5.09e-05	0.000442	CbGpPWpGaD
Sorafenib—CYP1A2—Metabolism of lipids and lipoproteins—PTGES—Barrett's esophagus	5.01e-05	0.000436	CbGpPWpGaD
Sorafenib—RAF1—TGF-beta Signaling Pathway—TP53—Barrett's esophagus	5e-05	0.000435	CbGpPWpGaD
Sorafenib—HTR2B—GPCR downstream signaling—SST—Barrett's esophagus	4.83e-05	0.00042	CbGpPWpGaD
Sorafenib—FGFR1—Disease—SLC9A1—Barrett's esophagus	4.83e-05	0.00042	CbGpPWpGaD
Sorafenib—PDGFRA—Disease—SLC9A1—Barrett's esophagus	4.81e-05	0.000419	CbGpPWpGaD
Sorafenib—RAF1—Cytokine Signaling in Immune system—RELA—Barrett's esophagus	4.74e-05	0.000412	CbGpPWpGaD
Sorafenib—RAF1—Signaling by NGF—RELA—Barrett's esophagus	4.66e-05	0.000405	CbGpPWpGaD
Sorafenib—FGFR1—Integrated Pancreatic Cancer Pathway—TP53—Barrett's esophagus	4.65e-05	0.000404	CbGpPWpGaD
Sorafenib—MAP3K7—Signaling Pathways—GAST—Barrett's esophagus	4.65e-05	0.000404	CbGpPWpGaD
Sorafenib—KIT—Signaling Pathways—GAST—Barrett's esophagus	4.65e-05	0.000404	CbGpPWpGaD
Sorafenib—FGFR1—Developmental Biology—PPARG—Barrett's esophagus	4.64e-05	0.000404	CbGpPWpGaD
Sorafenib—PDGFRA—Integrated Pancreatic Cancer Pathway—TP53—Barrett's esophagus	4.63e-05	0.000403	CbGpPWpGaD
Sorafenib—PDGFRB—MAPK Signaling Pathway—TP53—Barrett's esophagus	4.63e-05	0.000402	CbGpPWpGaD
Sorafenib—UGT1A1—Metabolism—CYP26A1—Barrett's esophagus	4.62e-05	0.000402	CbGpPWpGaD
Sorafenib—UGT1A9—Metabolism—CYP26A1—Barrett's esophagus	4.62e-05	0.000402	CbGpPWpGaD
Sorafenib—RALBP1—Signaling Pathways—APC—Barrett's esophagus	4.45e-05	0.000387	CbGpPWpGaD
Sorafenib—FGFR1—Signaling Pathways—GAST—Barrett's esophagus	4.41e-05	0.000384	CbGpPWpGaD
Sorafenib—PDGFRA—Signaling Pathways—GAST—Barrett's esophagus	4.4e-05	0.000383	CbGpPWpGaD
Sorafenib—MAPK11—Developmental Biology—RELA—Barrett's esophagus	4.39e-05	0.000382	CbGpPWpGaD
Sorafenib—HTR2B—Signaling by GPCR—SST—Barrett's esophagus	4.38e-05	0.000381	CbGpPWpGaD
Sorafenib—FLT4—Signaling Pathways—APC—Barrett's esophagus	4.38e-05	0.000381	CbGpPWpGaD
Sorafenib—HTR2B—Class A/1 (Rhodopsin-like receptors)—CXCL8—Barrett's esophagus	4.37e-05	0.00038	CbGpPWpGaD
Sorafenib—PDGFRB—Disease—SLC9A1—Barrett's esophagus	4.34e-05	0.000377	CbGpPWpGaD
Sorafenib—MAP2K5—Signaling Pathways—SST—Barrett's esophagus	4.21e-05	0.000367	CbGpPWpGaD
Sorafenib—MAPK11—Cellular responses to stress—TP53—Barrett's esophagus	4.19e-05	0.000365	CbGpPWpGaD
Sorafenib—RAF1—MAPK Signaling Pathway—TP53—Barrett's esophagus	4.12e-05	0.000359	CbGpPWpGaD
Sorafenib—KDR—Signaling Pathways—SST—Barrett's esophagus	4.11e-05	0.000357	CbGpPWpGaD
Sorafenib—RAF1—Signaling by GPCR—SST—Barrett's esophagus	4.1e-05	0.000356	CbGpPWpGaD
Sorafenib—EPHX2—Metabolism—PTGS2—Barrett's esophagus	4.04e-05	0.000351	CbGpPWpGaD
Sorafenib—PDGFRB—Signaling Pathways—GAST—Barrett's esophagus	3.96e-05	0.000345	CbGpPWpGaD
Sorafenib—MKNK1—Disease—PTGS2—Barrett's esophagus	3.93e-05	0.000342	CbGpPWpGaD
Sorafenib—ABCG2—Metabolism—CYP26A1—Barrett's esophagus	3.92e-05	0.000341	CbGpPWpGaD
Sorafenib—HTR2C—GPCR downstream signaling—SST—Barrett's esophagus	3.89e-05	0.000339	CbGpPWpGaD
Sorafenib—MAPK11—Immune System—HGF—Barrett's esophagus	3.89e-05	0.000339	CbGpPWpGaD
Sorafenib—ABCB1—Integrated Pancreatic Cancer Pathway—APC—Barrett's esophagus	3.88e-05	0.000338	CbGpPWpGaD
Sorafenib—CYP3A7—Metabolism—CYP26A1—Barrett's esophagus	3.88e-05	0.000338	CbGpPWpGaD
Sorafenib—MAPK11—Innate Immune System—RELA—Barrett's esophagus	3.88e-05	0.000337	CbGpPWpGaD
Sorafenib—RAF1—Disease—SLC9A1—Barrett's esophagus	3.87e-05	0.000336	CbGpPWpGaD
Sorafenib—CDK7—Gene Expression—PPARG—Barrett's esophagus	3.79e-05	0.00033	CbGpPWpGaD
Sorafenib—CYP2B6—Metabolism—PTGES—Barrett's esophagus	3.79e-05	0.00033	CbGpPWpGaD
Sorafenib—HTR2B—Signaling Pathways—GAST—Barrett's esophagus	3.78e-05	0.000329	CbGpPWpGaD
Sorafenib—FGFR1—Developmental Biology—RELA—Barrett's esophagus	3.76e-05	0.000327	CbGpPWpGaD
Sorafenib—RAF1—Integrated Pancreatic Cancer Pathway—TP53—Barrett's esophagus	3.72e-05	0.000324	CbGpPWpGaD
Sorafenib—RAF1—Developmental Biology—PPARG—Barrett's esophagus	3.72e-05	0.000323	CbGpPWpGaD
Sorafenib—CYP3A5—Metabolism—PTGES—Barrett's esophagus	3.7e-05	0.000322	CbGpPWpGaD
Sorafenib—CDK7—Disease—APC—Barrett's esophagus	3.65e-05	0.000317	CbGpPWpGaD
Sorafenib—MKNK1—Signaling Pathways—APC—Barrett's esophagus	3.63e-05	0.000315	CbGpPWpGaD
Sorafenib—HTR2C—Signaling by GPCR—SST—Barrett's esophagus	3.54e-05	0.000308	CbGpPWpGaD
Sorafenib—RAF1—Signaling Pathways—GAST—Barrett's esophagus	3.53e-05	0.000307	CbGpPWpGaD
Sorafenib—MAPK11—Signaling Pathways—SST—Barrett's esophagus	3.53e-05	0.000307	CbGpPWpGaD
Sorafenib—HTR2C—Class A/1 (Rhodopsin-like receptors)—CXCL8—Barrett's esophagus	3.53e-05	0.000307	CbGpPWpGaD
Sorafenib—KIT—Immune System—HGF—Barrett's esophagus	3.51e-05	0.000305	CbGpPWpGaD
Sorafenib—MAP3K7—Immune System—HGF—Barrett's esophagus	3.51e-05	0.000305	CbGpPWpGaD
Sorafenib—BRAF—Signaling Pathways—SST—Barrett's esophagus	3.5e-05	0.000304	CbGpPWpGaD
Sorafenib—KIT—Innate Immune System—RELA—Barrett's esophagus	3.5e-05	0.000304	CbGpPWpGaD
Sorafenib—MAP3K7—Innate Immune System—RELA—Barrett's esophagus	3.5e-05	0.000304	CbGpPWpGaD
Sorafenib—RALBP1—Signaling Pathways—RELA—Barrett's esophagus	3.48e-05	0.000302	CbGpPWpGaD
Sorafenib—FLT4—Signaling Pathways—RELA—Barrett's esophagus	3.42e-05	0.000298	CbGpPWpGaD
Sorafenib—UGT1A9—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	3.41e-05	0.000297	CbGpPWpGaD
Sorafenib—MAP3K7—Adaptive Immune System—RELA—Barrett's esophagus	3.36e-05	0.000292	CbGpPWpGaD
Sorafenib—KIT—Adaptive Immune System—RELA—Barrett's esophagus	3.36e-05	0.000292	CbGpPWpGaD
Sorafenib—FGFR1—Immune System—HGF—Barrett's esophagus	3.33e-05	0.00029	CbGpPWpGaD
Sorafenib—UGT1A1—Metabolism—SLC9A1—Barrett's esophagus	3.33e-05	0.00029	CbGpPWpGaD
Sorafenib—UGT1A9—Metabolism—SLC9A1—Barrett's esophagus	3.33e-05	0.00029	CbGpPWpGaD
Sorafenib—HTR2B—GPCR ligand binding—CXCL8—Barrett's esophagus	3.33e-05	0.000289	CbGpPWpGaD
Sorafenib—PDGFRA—Immune System—HGF—Barrett's esophagus	3.32e-05	0.000289	CbGpPWpGaD
Sorafenib—FGFR1—Innate Immune System—RELA—Barrett's esophagus	3.32e-05	0.000289	CbGpPWpGaD
Sorafenib—PDGFRA—Innate Immune System—RELA—Barrett's esophagus	3.31e-05	0.000288	CbGpPWpGaD
Sorafenib—RALBP1—Signaling Pathways—CXCL8—Barrett's esophagus	3.28e-05	0.000285	CbGpPWpGaD
Sorafenib—FLT1—Signaling Pathways—APC—Barrett's esophagus	3.27e-05	0.000284	CbGpPWpGaD
Sorafenib—ABCB1—Transmembrane transport of small molecules—SLC9A1—Barrett's esophagus	3.26e-05	0.000284	CbGpPWpGaD
Sorafenib—FLT4—Signaling Pathways—CXCL8—Barrett's esophagus	3.22e-05	0.00028	CbGpPWpGaD
Sorafenib—CDK7—Cell Cycle—TP53—Barrett's esophagus	3.21e-05	0.00028	CbGpPWpGaD
Sorafenib—CYP2C8—Metabolism—PTGES—Barrett's esophagus	3.21e-05	0.000279	CbGpPWpGaD
Sorafenib—FGFR1—Adaptive Immune System—RELA—Barrett's esophagus	3.19e-05	0.000277	CbGpPWpGaD
Sorafenib—MAP3K7—Signaling Pathways—SST—Barrett's esophagus	3.18e-05	0.000277	CbGpPWpGaD
Sorafenib—KIT—Signaling Pathways—SST—Barrett's esophagus	3.18e-05	0.000277	CbGpPWpGaD
Sorafenib—PDGFRA—Adaptive Immune System—RELA—Barrett's esophagus	3.18e-05	0.000276	CbGpPWpGaD
Sorafenib—HTR2C—Signaling Pathways—GAST—Barrett's esophagus	3.05e-05	0.000265	CbGpPWpGaD
Sorafenib—FGFR1—Signaling Pathways—SST—Barrett's esophagus	3.02e-05	0.000263	CbGpPWpGaD
Sorafenib—PDGFRA—Signaling Pathways—SST—Barrett's esophagus	3.01e-05	0.000262	CbGpPWpGaD
Sorafenib—RAF1—Developmental Biology—RELA—Barrett's esophagus	3.01e-05	0.000262	CbGpPWpGaD
Sorafenib—PDGFRB—Immune System—HGF—Barrett's esophagus	2.99e-05	0.00026	CbGpPWpGaD
Sorafenib—PDGFRB—Innate Immune System—RELA—Barrett's esophagus	2.98e-05	0.000259	CbGpPWpGaD
Sorafenib—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—Barrett's esophagus	2.95e-05	0.000256	CbGpPWpGaD
Sorafenib—CYP2B6—Metabolism—CYP26A1—Barrett's esophagus	2.87e-05	0.00025	CbGpPWpGaD
Sorafenib—CYP2C19—Metabolism—PTGES—Barrett's esophagus	2.86e-05	0.000249	CbGpPWpGaD
Sorafenib—PDGFRB—Adaptive Immune System—RELA—Barrett's esophagus	2.86e-05	0.000249	CbGpPWpGaD
Sorafenib—MKNK1—Signaling Pathways—RELA—Barrett's esophagus	2.83e-05	0.000247	CbGpPWpGaD
Sorafenib—ABCG2—Metabolism—SLC9A1—Barrett's esophagus	2.82e-05	0.000246	CbGpPWpGaD
Sorafenib—CYP3A5—Metabolism—CYP26A1—Barrett's esophagus	2.81e-05	0.000244	CbGpPWpGaD
Sorafenib—CYP3A7—Metabolism—SLC9A1—Barrett's esophagus	2.8e-05	0.000244	CbGpPWpGaD
Sorafenib—ABCB1—Metabolism—PTGES—Barrett's esophagus	2.79e-05	0.000243	CbGpPWpGaD
Sorafenib—MAPK11—Gene Expression—PPARG—Barrett's esophagus	2.77e-05	0.000241	CbGpPWpGaD
Sorafenib—CDK7—Disease—PTGS2—Barrett's esophagus	2.77e-05	0.000241	CbGpPWpGaD
Sorafenib—PDGFRB—Signaling Pathways—SST—Barrett's esophagus	2.72e-05	0.000236	CbGpPWpGaD
Sorafenib—HTR2C—GPCR ligand binding—CXCL8—Barrett's esophagus	2.68e-05	0.000234	CbGpPWpGaD
Sorafenib—UGT1A9—Metabolism of lipids and lipoproteins—PTGS2—Barrett's esophagus	2.68e-05	0.000233	CbGpPWpGaD
Sorafenib—MKNK1—Signaling Pathways—CXCL8—Barrett's esophagus	2.67e-05	0.000232	CbGpPWpGaD
Sorafenib—RAF1—Immune System—HGF—Barrett's esophagus	2.67e-05	0.000232	CbGpPWpGaD
Sorafenib—RAF1—Innate Immune System—RELA—Barrett's esophagus	2.66e-05	0.000231	CbGpPWpGaD
Sorafenib—BRAF—Disease—APC—Barrett's esophagus	2.64e-05	0.00023	CbGpPWpGaD
Sorafenib—CYP2D6—Metabolism—PTGES—Barrett's esophagus	2.63e-05	0.000229	CbGpPWpGaD
Sorafenib—CYP2C9—Metabolism—PTGES—Barrett's esophagus	2.61e-05	0.000227	CbGpPWpGaD
Sorafenib—HTR2B—Signaling Pathways—SST—Barrett's esophagus	2.59e-05	0.000225	CbGpPWpGaD
Sorafenib—FLT1—Signaling Pathways—RELA—Barrett's esophagus	2.55e-05	0.000222	CbGpPWpGaD
Sorafenib—RAF1—Adaptive Immune System—RELA—Barrett's esophagus	2.55e-05	0.000222	CbGpPWpGaD
Sorafenib—CYP2C8—Metabolism—CYP26A1—Barrett's esophagus	2.43e-05	0.000212	CbGpPWpGaD
Sorafenib—RAF1—Signaling Pathways—SST—Barrett's esophagus	2.42e-05	0.000211	CbGpPWpGaD
Sorafenib—KIT—Disease—APC—Barrett's esophagus	2.41e-05	0.000209	CbGpPWpGaD
Sorafenib—FLT1—Signaling Pathways—CXCL8—Barrett's esophagus	2.4e-05	0.000209	CbGpPWpGaD
Sorafenib—FGFR1—Disease—APC—Barrett's esophagus	2.28e-05	0.000199	CbGpPWpGaD
Sorafenib—PDGFRA—Disease—APC—Barrett's esophagus	2.28e-05	0.000198	CbGpPWpGaD
Sorafenib—MAPK11—Immune System—RELA—Barrett's esophagus	2.26e-05	0.000196	CbGpPWpGaD
Sorafenib—CYP1A2—Metabolism—PTGES—Barrett's esophagus	2.23e-05	0.000194	CbGpPWpGaD
Sorafenib—MAP2K5—Signaling Pathways—APC—Barrett's esophagus	2.23e-05	0.000194	CbGpPWpGaD
Sorafenib—KDR—Signaling Pathways—APC—Barrett's esophagus	2.17e-05	0.000189	CbGpPWpGaD
Sorafenib—CYP2C19—Metabolism—CYP26A1—Barrett's esophagus	2.17e-05	0.000189	CbGpPWpGaD
Sorafenib—ABCB1—Metabolism—CYP26A1—Barrett's esophagus	2.12e-05	0.000184	CbGpPWpGaD
Sorafenib—HTR2C—Signaling Pathways—SST—Barrett's esophagus	2.09e-05	0.000182	CbGpPWpGaD
Sorafenib—CYP2B6—Metabolism—SLC9A1—Barrett's esophagus	2.07e-05	0.00018	CbGpPWpGaD
Sorafenib—PDGFRB—Disease—APC—Barrett's esophagus	2.05e-05	0.000178	CbGpPWpGaD
Sorafenib—KIT—Immune System—RELA—Barrett's esophagus	2.04e-05	0.000177	CbGpPWpGaD
Sorafenib—MAP3K7—Immune System—RELA—Barrett's esophagus	2.04e-05	0.000177	CbGpPWpGaD
Sorafenib—ABCC4—Hemostasis—TP53—Barrett's esophagus	2.03e-05	0.000177	CbGpPWpGaD
Sorafenib—CYP3A5—Metabolism—SLC9A1—Barrett's esophagus	2.02e-05	0.000176	CbGpPWpGaD
Sorafenib—RALBP1—Signaling Pathways—TP53—Barrett's esophagus	2.01e-05	0.000175	CbGpPWpGaD
Sorafenib—BRAF—Disease—PTGS2—Barrett's esophagus	2.01e-05	0.000175	CbGpPWpGaD
Sorafenib—CYP2D6—Metabolism—CYP26A1—Barrett's esophagus	2e-05	0.000174	CbGpPWpGaD
Sorafenib—CYP2C9—Metabolism—CYP26A1—Barrett's esophagus	1.98e-05	0.000172	CbGpPWpGaD
Sorafenib—FLT4—Signaling Pathways—TP53—Barrett's esophagus	1.98e-05	0.000172	CbGpPWpGaD
Sorafenib—FGFR1—Immune System—RELA—Barrett's esophagus	1.93e-05	0.000168	CbGpPWpGaD
Sorafenib—PDGFRA—Immune System—RELA—Barrett's esophagus	1.93e-05	0.000168	CbGpPWpGaD
Sorafenib—HTR2B—GPCR downstream signaling—CXCL8—Barrett's esophagus	1.88e-05	0.000164	CbGpPWpGaD
Sorafenib—MAPK11—Signaling Pathways—APC—Barrett's esophagus	1.87e-05	0.000163	CbGpPWpGaD
Sorafenib—BRAF—Signaling Pathways—APC—Barrett's esophagus	1.85e-05	0.000161	CbGpPWpGaD
Sorafenib—RAF1—Disease—APC—Barrett's esophagus	1.83e-05	0.000159	CbGpPWpGaD
Sorafenib—KIT—Disease—PTGS2—Barrett's esophagus	1.83e-05	0.000159	CbGpPWpGaD
Sorafenib—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	1.8e-05	0.000156	CbGpPWpGaD
Sorafenib—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—Barrett's esophagus	1.75e-05	0.000153	CbGpPWpGaD
Sorafenib—CYP2C8—Metabolism—SLC9A1—Barrett's esophagus	1.75e-05	0.000152	CbGpPWpGaD
Sorafenib—MAP2K5—Signaling Pathways—RELA—Barrett's esophagus	1.74e-05	0.000152	CbGpPWpGaD
Sorafenib—PDGFRB—Immune System—RELA—Barrett's esophagus	1.74e-05	0.000151	CbGpPWpGaD
Sorafenib—FGFR1—Disease—PTGS2—Barrett's esophagus	1.73e-05	0.000151	CbGpPWpGaD
Sorafenib—PDGFRA—Disease—PTGS2—Barrett's esophagus	1.73e-05	0.00015	CbGpPWpGaD
Sorafenib—CYP3A4—Metabolism—PTGES—Barrett's esophagus	1.72e-05	0.00015	CbGpPWpGaD
Sorafenib—HTR2B—Signaling by GPCR—CXCL8—Barrett's esophagus	1.71e-05	0.000149	CbGpPWpGaD
Sorafenib—RAF1—Hemostasis—TP53—Barrett's esophagus	1.71e-05	0.000148	CbGpPWpGaD
Sorafenib—KDR—Signaling Pathways—RELA—Barrett's esophagus	1.7e-05	0.000148	CbGpPWpGaD
Sorafenib—CYP1A2—Metabolism—CYP26A1—Barrett's esophagus	1.69e-05	0.000147	CbGpPWpGaD
Sorafenib—MAP3K7—Signaling Pathways—APC—Barrett's esophagus	1.68e-05	0.000147	CbGpPWpGaD
Sorafenib—KIT—Signaling Pathways—APC—Barrett's esophagus	1.68e-05	0.000147	CbGpPWpGaD
Sorafenib—MAP2K5—Signaling Pathways—CXCL8—Barrett's esophagus	1.64e-05	0.000143	CbGpPWpGaD
Sorafenib—MKNK1—Signaling Pathways—TP53—Barrett's esophagus	1.64e-05	0.000143	CbGpPWpGaD
Sorafenib—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	1.6e-05	0.000139	CbGpPWpGaD
Sorafenib—KDR—Signaling Pathways—CXCL8—Barrett's esophagus	1.6e-05	0.000139	CbGpPWpGaD
Sorafenib—FGFR1—Signaling Pathways—APC—Barrett's esophagus	1.6e-05	0.000139	CbGpPWpGaD
Sorafenib—RAF1—Signaling by GPCR—CXCL8—Barrett's esophagus	1.6e-05	0.000139	CbGpPWpGaD
Sorafenib—PDGFRA—Signaling Pathways—APC—Barrett's esophagus	1.59e-05	0.000139	CbGpPWpGaD
Sorafenib—CYP2C19—Metabolism—SLC9A1—Barrett's esophagus	1.56e-05	0.000136	CbGpPWpGaD
Sorafenib—PDGFRB—Disease—PTGS2—Barrett's esophagus	1.56e-05	0.000135	CbGpPWpGaD
Sorafenib—RAF1—Immune System—RELA—Barrett's esophagus	1.55e-05	0.000135	CbGpPWpGaD
Sorafenib—ABCB1—Metabolism—SLC9A1—Barrett's esophagus	1.53e-05	0.000133	CbGpPWpGaD
Sorafenib—UGT1A1—Metabolism—PPARG—Barrett's esophagus	1.52e-05	0.000132	CbGpPWpGaD
Sorafenib—UGT1A9—Metabolism—PPARG—Barrett's esophagus	1.52e-05	0.000132	CbGpPWpGaD
Sorafenib—HTR2C—GPCR downstream signaling—CXCL8—Barrett's esophagus	1.52e-05	0.000132	CbGpPWpGaD
Sorafenib—FLT1—Signaling Pathways—TP53—Barrett's esophagus	1.48e-05	0.000128	CbGpPWpGaD
Sorafenib—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	1.46e-05	0.000127	CbGpPWpGaD
Sorafenib—MAPK11—Signaling Pathways—RELA—Barrett's esophagus	1.46e-05	0.000127	CbGpPWpGaD
Sorafenib—BRAF—Signaling Pathways—RELA—Barrett's esophagus	1.45e-05	0.000126	CbGpPWpGaD
Sorafenib—CYP2D6—Metabolism—SLC9A1—Barrett's esophagus	1.44e-05	0.000125	CbGpPWpGaD
Sorafenib—PDGFRB—Signaling Pathways—APC—Barrett's esophagus	1.44e-05	0.000125	CbGpPWpGaD
Sorafenib—CYP2C9—Metabolism—SLC9A1—Barrett's esophagus	1.43e-05	0.000124	CbGpPWpGaD
Sorafenib—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—Barrett's esophagus	1.41e-05	0.000123	CbGpPWpGaD
Sorafenib—RAF1—Disease—PTGS2—Barrett's esophagus	1.39e-05	0.000121	CbGpPWpGaD
Sorafenib—HTR2C—Signaling by GPCR—CXCL8—Barrett's esophagus	1.38e-05	0.00012	CbGpPWpGaD
Sorafenib—MAPK11—Signaling Pathways—CXCL8—Barrett's esophagus	1.38e-05	0.00012	CbGpPWpGaD
Sorafenib—HTR2B—Signaling Pathways—APC—Barrett's esophagus	1.37e-05	0.000119	CbGpPWpGaD
Sorafenib—BRAF—Signaling Pathways—CXCL8—Barrett's esophagus	1.36e-05	0.000119	CbGpPWpGaD
Sorafenib—MAP3K7—Signaling Pathways—RELA—Barrett's esophagus	1.32e-05	0.000115	CbGpPWpGaD
Sorafenib—KIT—Signaling Pathways—RELA—Barrett's esophagus	1.32e-05	0.000115	CbGpPWpGaD
Sorafenib—CYP3A4—Metabolism—CYP26A1—Barrett's esophagus	1.31e-05	0.000114	CbGpPWpGaD
Sorafenib—ABCG2—Metabolism—PPARG—Barrett's esophagus	1.29e-05	0.000112	CbGpPWpGaD
Sorafenib—RAF1—Signaling Pathways—APC—Barrett's esophagus	1.28e-05	0.000111	CbGpPWpGaD
Sorafenib—CYP3A7—Metabolism—PPARG—Barrett's esophagus	1.28e-05	0.000111	CbGpPWpGaD
Sorafenib—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—Barrett's esophagus	1.26e-05	0.00011	CbGpPWpGaD
Sorafenib—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	1.25e-05	0.000109	CbGpPWpGaD
Sorafenib—FGFR1—Signaling Pathways—RELA—Barrett's esophagus	1.25e-05	0.000109	CbGpPWpGaD
Sorafenib—PDGFRA—Signaling Pathways—RELA—Barrett's esophagus	1.25e-05	0.000108	CbGpPWpGaD
Sorafenib—MAP3K7—Signaling Pathways—CXCL8—Barrett's esophagus	1.24e-05	0.000108	CbGpPWpGaD
Sorafenib—KIT—Signaling Pathways—CXCL8—Barrett's esophagus	1.24e-05	0.000108	CbGpPWpGaD
Sorafenib—CYP1A2—Metabolism—SLC9A1—Barrett's esophagus	1.22e-05	0.000106	CbGpPWpGaD
Sorafenib—UGT1A1—Metabolism—PTGS2—Barrett's esophagus	1.2e-05	0.000104	CbGpPWpGaD
Sorafenib—UGT1A9—Metabolism—PTGS2—Barrett's esophagus	1.2e-05	0.000104	CbGpPWpGaD
Sorafenib—FGFR1—Signaling Pathways—CXCL8—Barrett's esophagus	1.18e-05	0.000102	CbGpPWpGaD
Sorafenib—PDGFRA—Signaling Pathways—CXCL8—Barrett's esophagus	1.17e-05	0.000102	CbGpPWpGaD
Sorafenib—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—Barrett's esophagus	1.15e-05	0.0001	CbGpPWpGaD
Sorafenib—PDGFRB—Signaling Pathways—RELA—Barrett's esophagus	1.12e-05	9.77e-05	CbGpPWpGaD
Sorafenib—HTR2C—Signaling Pathways—APC—Barrett's esophagus	1.11e-05	9.62e-05	CbGpPWpGaD
Sorafenib—HTR2B—Signaling Pathways—RELA—Barrett's esophagus	1.07e-05	9.31e-05	CbGpPWpGaD
Sorafenib—PDGFRB—Signaling Pathways—CXCL8—Barrett's esophagus	1.06e-05	9.2e-05	CbGpPWpGaD
Sorafenib—ABCG2—Metabolism—PTGS2—Barrett's esophagus	1.01e-05	8.82e-05	CbGpPWpGaD
Sorafenib—HTR2B—Signaling Pathways—CXCL8—Barrett's esophagus	1.01e-05	8.78e-05	CbGpPWpGaD
Sorafenib—MAP2K5—Signaling Pathways—TP53—Barrett's esophagus	1.01e-05	8.76e-05	CbGpPWpGaD
Sorafenib—CYP3A7—Metabolism—PTGS2—Barrett's esophagus	1.01e-05	8.74e-05	CbGpPWpGaD
Sorafenib—RAF1—Signaling Pathways—RELA—Barrett's esophagus	1e-05	8.7e-05	CbGpPWpGaD
Sorafenib—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—Barrett's esophagus	9.83e-06	8.55e-05	CbGpPWpGaD
Sorafenib—KDR—Signaling Pathways—TP53—Barrett's esophagus	9.82e-06	8.54e-05	CbGpPWpGaD
Sorafenib—CYP2B6—Metabolism—PPARG—Barrett's esophagus	9.45e-06	8.22e-05	CbGpPWpGaD
Sorafenib—RAF1—Signaling Pathways—CXCL8—Barrett's esophagus	9.43e-06	8.2e-05	CbGpPWpGaD
Sorafenib—CYP3A4—Metabolism—SLC9A1—Barrett's esophagus	9.41e-06	8.18e-05	CbGpPWpGaD
Sorafenib—CYP3A5—Metabolism—PPARG—Barrett's esophagus	9.24e-06	8.04e-05	CbGpPWpGaD
Sorafenib—HTR2C—Signaling Pathways—RELA—Barrett's esophagus	8.64e-06	7.51e-05	CbGpPWpGaD
Sorafenib—MAPK11—Signaling Pathways—TP53—Barrett's esophagus	8.44e-06	7.34e-05	CbGpPWpGaD
Sorafenib—BRAF—Signaling Pathways—TP53—Barrett's esophagus	8.36e-06	7.28e-05	CbGpPWpGaD
Sorafenib—HTR2C—Signaling Pathways—CXCL8—Barrett's esophagus	8.14e-06	7.08e-05	CbGpPWpGaD
Sorafenib—CYP2C8—Metabolism—PPARG—Barrett's esophagus	8e-06	6.96e-05	CbGpPWpGaD
Sorafenib—KIT—Signaling Pathways—TP53—Barrett's esophagus	7.61e-06	6.62e-05	CbGpPWpGaD
Sorafenib—MAP3K7—Signaling Pathways—TP53—Barrett's esophagus	7.61e-06	6.62e-05	CbGpPWpGaD
Sorafenib—CYP2B6—Metabolism—PTGS2—Barrett's esophagus	7.43e-06	6.47e-05	CbGpPWpGaD
Sorafenib—CYP3A5—Metabolism—PTGS2—Barrett's esophagus	7.27e-06	6.32e-05	CbGpPWpGaD
Sorafenib—FGFR1—Signaling Pathways—TP53—Barrett's esophagus	7.22e-06	6.28e-05	CbGpPWpGaD
Sorafenib—PDGFRA—Signaling Pathways—TP53—Barrett's esophagus	7.21e-06	6.27e-05	CbGpPWpGaD
Sorafenib—CYP2C19—Metabolism—PPARG—Barrett's esophagus	7.14e-06	6.21e-05	CbGpPWpGaD
Sorafenib—ABCB1—Metabolism—PPARG—Barrett's esophagus	6.97e-06	6.06e-05	CbGpPWpGaD
Sorafenib—CYP2D6—Metabolism—PPARG—Barrett's esophagus	6.57e-06	5.71e-05	CbGpPWpGaD
Sorafenib—CYP2C9—Metabolism—PPARG—Barrett's esophagus	6.51e-06	5.66e-05	CbGpPWpGaD
Sorafenib—PDGFRB—Signaling Pathways—TP53—Barrett's esophagus	6.49e-06	5.65e-05	CbGpPWpGaD
Sorafenib—CYP2C8—Metabolism—PTGS2—Barrett's esophagus	6.29e-06	5.47e-05	CbGpPWpGaD
Sorafenib—HTR2B—Signaling Pathways—TP53—Barrett's esophagus	6.19e-06	5.39e-05	CbGpPWpGaD
Sorafenib—RAF1—Signaling Pathways—TP53—Barrett's esophagus	5.79e-06	5.03e-05	CbGpPWpGaD
Sorafenib—CYP2C19—Metabolism—PTGS2—Barrett's esophagus	5.62e-06	4.89e-05	CbGpPWpGaD
Sorafenib—CYP1A2—Metabolism—PPARG—Barrett's esophagus	5.56e-06	4.84e-05	CbGpPWpGaD
Sorafenib—ABCB1—Metabolism—PTGS2—Barrett's esophagus	5.48e-06	4.77e-05	CbGpPWpGaD
Sorafenib—CYP2D6—Metabolism—PTGS2—Barrett's esophagus	5.17e-06	4.49e-05	CbGpPWpGaD
Sorafenib—CYP2C9—Metabolism—PTGS2—Barrett's esophagus	5.12e-06	4.46e-05	CbGpPWpGaD
Sorafenib—HTR2C—Signaling Pathways—TP53—Barrett's esophagus	4.99e-06	4.35e-05	CbGpPWpGaD
Sorafenib—CYP1A2—Metabolism—PTGS2—Barrett's esophagus	4.38e-06	3.81e-05	CbGpPWpGaD
Sorafenib—CYP3A4—Metabolism—PPARG—Barrett's esophagus	4.29e-06	3.74e-05	CbGpPWpGaD
Sorafenib—CYP3A4—Metabolism—PTGS2—Barrett's esophagus	3.38e-06	2.94e-05	CbGpPWpGaD
